NEWS

Oct 22 (Reuters) – President Donald Trump’s administration is preparing a new probe into drug pricing practices among U.S. trading partners, a move that would lay the ground for fresh tariffs, the Financial Times reported on Wednesday, citing sources familiar with the matter.

Read more here.